Login Register Cart 0
Generic placeholder image

Current HIV Research

Editor-in-Chief

ISSN (Print): 1570-162X
ISSN (Online): 1873-4251

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Case Report

Differential Diagnosis or Etiology: A Case Report on Amyotrophic Lateral Sclerosis-like Neuropathy Associated with HIV Infection

Author(s): Renato Barradas Rodrigues*, Marco Orsini, Sofia Vieira Neves, Wladimir Bocca Vieira de Rezende Pinto, Antônio Marcos da Silva Catarino, Daniel Antunes Pereira and Acary Souza Bulle Oliveira

Volume 21, Issue 5, 2023

Published on: 16 October, 2023

Page: [323 - 329] Pages: 7

DOI: 10.2174/1570162X21666230914104220

Price: $65

Abstract

Background: Retroviruses are described as a risk factor for chronic neuropathy. However, it is still unknown if they can work as amyotrophic lateral sclerosis triggers. Over the years, some cases of this association have been described with heterogenous disclosures.

Case Representation: This study aimed to report a case of HIV and ALS-like neuropathy and briefly discuss peculiarities of clinical aspects, such as physiopathology and treatment options. The patient underwent neurological examination associated with blood tests, electromyography, analysis of cerebrospinal fluid, and imaging studies.

Discussion: A non-systematic review was performed in major databases regarding the topic. The case presented mixed upper and lower motor neuron signs and was framed as a probable case of ALS following the present criteria.

Conclusion: After a short follow-up and viral load cleansing, neurological stabilization was achieved.

« Previous
Graphical Abstract

[1]
Longinetti E, Fang F. Epidemiology of amyotrophic lateral sclerosis: An update of recent literature. Curr Opin Neurol 2019; 32(5): 771-6.
[http://dx.doi.org/10.1097/WCO.0000000000000730] [PMID: 31361627]
[2]
Erazo D, Luna J, Preux PM, Boumediene F, Couratier P. Epidemiological and genetic features of amyotrophic lateral sclerosis in Latin America and the Caribbean: A systematic review. Amyotroph Lateral Scler Frontotemporal Degener 2022; 23(1-2): 4-15.
[http://dx.doi.org/10.1080/21678421.2021.1909066]
[3]
Logroscino G, Piccininni M. Amyotrophic lateral sclerosis descriptive epidemiology: The origin of geographic difference. Neuroepidemiology 2019; 52(1-2): 93-103.
[http://dx.doi.org/10.1159/000493386] [PMID: 30602169]
[4]
van Es MA, Hardiman O, Chio A, et al. Amyotrophic lateral sclerosis. Lancet 2017; 390(10107): 2084-98.
[http://dx.doi.org/10.1016/S0140-6736(17)31287-4]
[5]
Mejzini R, Flynn LL, Pitout IL, Fletcher S, Wilton SD, Akkari PA. ALS genetics, mechanisms, and therapeutics: Where are we now? Front Neurosci 2019; 13: 1310.
[http://dx.doi.org/10.3389/fnins.2019.01310] [PMID: 31866818]
[6]
Vijayakumar UG, Milla V, Cynthia Stafford MY, Bjourson AJ, Duddy W, Duguez SMR. A systematic review of suggested molecular strata, biomarkers and their tissue sources in ALS. Front Neurol 2019; 10(MAY): 400.
[http://dx.doi.org/10.3389/fneur.2019.00400] [PMID: 31139131]
[7]
Rinaldi F, Motti D, Ferraiuolo L, Kaspar BK. High content analysis in amyotrophic lateral sclerosis. Mol Cell Neurosci 2017; 80: 180-91.
[http://dx.doi.org/10.1016/j.mcn.2016.12.001] [PMID: 27965018]
[8]
Celeste DB, Miller MS. Reviewing the evidence for viruses as environmental risk factors for ALS: A new perspective. Cytokine 2018; 108: 173-8.
[http://dx.doi.org/10.1016/j.cyto.2018.04.010] [PMID: 29684753]
[9]
Wang MD, Little J, Gomes J, Cashman NR, Krewski D. Identification of risk factors associated with onset and progression of amyotrophic lateral sclerosis using systematic review and meta-analysis. Neurotoxicology 2017; 61: 101-30.
[http://dx.doi.org/10.1016/j.neuro.2016.06.015] [PMID: 27377857]
[10]
Castanedo-Vazquez D, Bosque-Varela P, Sainz-Pelayo A, Riancho J. Infectious agents and amyotrophic lateral sclerosis: another piece of the puzzle of motor neuron degeneration. J Neurol 2019; 266(1): 27-36.
[http://dx.doi.org/10.1007/s00415-018-8919-3] [PMID: 29845377]
[11]
Alfahad T, Nath A. Retroviruses and amyotrophic lateral sclerosis. Antiviral Res 2013; 99(2): 180-7.
[http://dx.doi.org/10.1016/j.antiviral.2013.05.006] [PMID: 23707220]
[12]
Sodeifian F. Juvenile amyotrophic lateral sclerosis in 16 years old girl with HIV. Neurol Lett 2022; 1(1): 44-6. Available from: https://www.neurologyletters.com/article_158189.html
[http://dx.doi.org/10.52547/nl.1.1.44]
[13]
Grad LI, Rouleau GA, Ravits J, Cashman NR. Clinical spectrum of amyotrophic lateral sclerosis (ALS). Cold Spring Harb Perspect Med 2017; 7(8): a024117.
[http://dx.doi.org/10.1101/cshperspect.a024117] [PMID: 28003278]
[14]
Brooks BR, Miller RG, Swash M, Munsat TL. El Escorial revisited: Revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 2000; 1(5): 293-9.
[http://dx.doi.org/10.1080/146608200300079536] [PMID: 11464847]
[15]
Costa J, Swash M, de Carvalho M. Awaji criteria for the diagnosis of amyotrophic lateral sclerosis: A systematic review. Arch Neurol 2012; 69(11): 1410-6.
[http://dx.doi.org/10.1001/archneurol.2012.254] [PMID: 22892641]
[16]
Shefner JM, Al-Chalabi A, Baker MR, et al. A proposal for new diagnostic criteria for ALS. Clin Neurophysiol 2020; 131(8): 1975-8.
[http://dx.doi.org/10.1016/j.clinph.2020.04.005]
[17]
Masrori P, Van Damme P. Amyotrophic lateral sclerosis: A clinical review. Eur J Neurol 2020; 27(10): 1918-29.
[http://dx.doi.org/10.1111/ene.14393] [PMID: 32526057]
[18]
Oskarsson B, Gendron TF, Staff NP. Amyotrophic lateral sclerosis: An update for 2018. Mayo Clin Proc 2018; 93(11): 1617-28.
[http://dx.doi.org/10.1016/j.mayocp.2018.04.007] [PMID: 30401437]
[19]
Meng L, Li X, Li C, et al. Effects of exercise in patients with amyotrophic lateral sclerosis: A systematic review and meta-analysis. Am J Phys Med Rehabil 2020; 99(9): 801-10.
[http://dx.doi.org/10.1097/PHM.0000000000001419] [PMID: 32452880]
[20]
Kaku M, Simpson DM. HIV neuropathy. Curr Opin HIV AIDS 2014; 9(6): 521-6.
[http://dx.doi.org/10.1097/COH.0000000000000103]
[21]
Rowland LP. HIV-related neuromuscular diseases: Nemaline myopathy, amyotrophic lateral sclerosis and bibrachial amyotrophic diplegia. Acta Myologica 2011; 30(1): 29-31.
[22]
Li W, Pandya D, Pasternack N, et al. Retroviral elements in pathophysiology and as therapeutic targets for amyotrophic lateral sclerosis. Neurotherapeutics 2022; 19(4): 1085-101.
[http://dx.doi.org/10.1007/s13311-022-01233-8] [PMID: 35415778]
[23]
Verma A, Berger JR. ALS syndrome in patients with HIV-1 infection. J Neurol Sci 2006; 240(1-2): 59-64.
[http://dx.doi.org/10.1016/j.jns.2005.09.005] [PMID: 16236322]
[24]
Orsini M, de Freitas MRG, Silva JG, et al. Motor neuron disease and acquired axonal neuropathy association in HIV infection: Case report and update. Curr HIV Res 2012; 10(8): 694-9.
[http://dx.doi.org/10.2174/157016212803901329] [PMID: 22998474]
[25]
Lorenzoni PJ, Ducci RDP, Dalledone GO, et al. Motor neuron disease in patients with HIV infection: Report of two cases and brief review of the literature. Clin Neurol Neurosurg 2018; 171: 139-42.
[http://dx.doi.org/10.1016/j.clineuro.2018.06.006] [PMID: 29909186]
[26]
Jones AR, Iacoangeli A, Adey BN, et al. A HML6 endogenous retrovirus on chromosome 3 is upregulated in amyotrophic lateral sclerosis motor cortex. Sci Rep 2021; 11(1): 14283.
[http://dx.doi.org/10.1038/s41598-021-93742-3] [PMID: 34253796]
[27]
Christensen T. Human endogenous retroviruses in neurologic disease. Acta Pathol Microbiol Scand Suppl 2016; 124(1-2): 116-26.
[http://dx.doi.org/10.1111/apm.12486]
[28]
Douville RN, Nath A. Human endogenous retrovirus-K and TDP-43 expression bridges ALS and HIV neuropathology. Front Microbiol 2017; 8(OCT): 1986.
[http://dx.doi.org/10.3389/fmicb.2017.01986] [PMID: 29075249]
[29]
Cai Y, Arikkath J, Yang L, Guo ML, Periyasamy P, Buch S. Interplay of endoplasmic reticulum stress and autophagy in neurodegenerative disorders. Autophagy 2016; 12(2): 225-44.
[http://dx.doi.org/10.1080/15548627.2015.1121360] [PMID: 26902584]
[30]
Moodley K, Bill PLA, Bhigjee AI, Patel VB. A comparative study of motor neuron disease in HIV-infected and HIV-uninfected patients. J Neurol Sci 2019; 397: 96-102.
[http://dx.doi.org/10.1016/j.jns.2018.12.030] [PMID: 30597421]
[31]
Chakrabarti S, Pan K, Mondal K, Panchadhyayee S. Amyotrophic lateral sclerosis as sole neurological manifestation of human immunodeficiency virus. JHIV and Hum Reprod 2014; 2(1): 30.
[http://dx.doi.org/10.4103/2321-9157.135746]
[32]
Anand KS, Wadhwa A, Garg J, Mahajan RK. Amyotrophic lateral sclerosis-like presentation in a HIV-positive patient. J Int Assoc Provid AIDS Care 2014; 13(6): 515-8.
[http://dx.doi.org/10.1177/2325957414535254] [PMID: 24842949]
[33]
Quevedo-Ramirez A, Montenegro-Idrogo JJ, Resurrección-Delgado C, et al. Lateral amyotrophic sclerosis-like onset after combined antiretroviral treatment initiation. IDCases 2020; 22: e00994.
[http://dx.doi.org/10.1016/j.idcr.2020.e00994] [PMID: 33194549]
[34]
Authier FJ, Gheradi RK. Peripheral neuropathies in HIV-infected patients in the era of HAART. Brain Pathol 2003; 13(2): 223-8.
[http://dx.doi.org/10.1111/j.1750-3639.2003.tb00021.x]
[35]
Garcia-Montojo M, Fathi S, Norato G, et al. Inhibition of HERV-K (HML-2) in amyotrophic lateral sclerosis patients on antiretroviral therapy. J Neurol Sci 2021; 423: 117358.
[http://dx.doi.org/10.1016/j.jns.2021.117358] [PMID: 33653604]
[36]
Bowen LN, Tyagi R, Li W. HIV-associated motor neuron disease. Neurology 2021; 87: 17.
[37]
Yoshino H, Tyagi R, Li W, Alfahad T, Smith B, Wright M, et al. Edaravone for the treatment of amyotrophic lateral sclerosis. Expert Rev Neurother 2019; 19(3): 185-93.
[http://dx.doi.org/10.1080/14737175.2019.1581610] [PMID: 30810406]
[38]
Jaiswal MK. Riluzole and edaravone: A tale of two amyotrophic lateral sclerosis drugs. Med Res Rev 2019; 39(2): 733-48.
[http://dx.doi.org/10.1002/med.21528] [PMID: 30101496]
[39]
Khalid SI, Ampie L, Kelly R. Immune modulation in the treatment of amyotrophic lateral sclerosis: A review of clinical trials. Frontiers in Neurology 2017; 8: 486.
[40]
John AA, Sharma S, Madhusudhan BK, Mahale R, Javali M, Srinivasa R. A rare presentation of reversible ALS in HIV infection. HIV AIDS Rev 2015; 14(3): 90-2.
[http://dx.doi.org/10.1016/j.hivar.2015.02.004]
[41]
Khalid SI, Ampie L, Kelly R, Ladha SS, Dardis C. Immune modulation in the treatment of amyotrophic lateral sclerosis: A review of clinical trials. Front Neurol 2017; 8: 486.
[http://dx.doi.org/10.3389/fneur.2017.00486] [PMID: 28993751]

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy